{"name":"CERo Therapeutics Holdings, Inc.","slug":"cero-therapeutics-holdings-inc","ticker":"","exchange":"","domain":"cero.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"CER-1236","genericName":"CER-1236","slug":"cer-1236","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"CER-1236","genericName":"CER-1236","slug":"cer-1236","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFBYNzFVSGdhQ2JLVFB0T1dfYllUSDlucER0alFCNWU2TEJRWXBFcDdQdkUyVVBqaFNrMHZfMWJGc24zMThHenAtZHBlQ25meWh2Q2lvcnItVl9tblVSTTIySm5SM09fSHNSSDBfaldR?oc=5","date":"2026-03-22","type":"pipeline","source":"Stock Titan","summary":"If You Invested $1,000 in CERo Therapeutics (CERO) - Stock Titan","headline":"If You Invested $1,000 in CERo Therapeutics (CERO)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxPOEdiWnYwUzVtbUZTa3BhNmJwemxJbkFSa2JmSkZfOWhKYVJDaGlZZTg4VlJBb3pNaVk3d2lnVFVQcDNVX1BsbzhwdzNteThFYjk0LWpVX0tEMS1KZFRwcjdHQlpoTjNFcXN2RTZaZ1pLNzREN0s5NldJUl9qenhGVlhLd0VsdFM1bzlWRzVZRUlIejVWUEFrbm9CVFdBamxIQUVFaFI0UmhMVVhHZXNtN2h5WlByMTNncEtHRUZwZEVpX0UxbGVRSkdOVQ?oc=5","date":"2026-03-12","type":"pipeline","source":"Stock Titan","summary":"Cero Therapeutics (NASDAQ: CERO) holder Isaiah Tibbs reports 8.67% stake - Stock Titan","headline":"Cero Therapeutics (NASDAQ: CERO) holder Isaiah Tibbs reports 8.67% stake","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxNNHBDYlZFSUZhVnRxTE12bnRxOVVJRDR0STd6OUc3ZjRMdkFXX1NLckxsMTJRN3AtNjBNbTRvZVRvUjNsTndROFYxb05wSEQ4Z3JKb0JKa09sVTdaSmxmdE1oc1plajgyT0JRVG9jOGx4X2dBME53cjZRR1lJZWd4SVY1cDRTcGFTNlJPYU1iUExEcE1CMmlnMGRyRlFhZUU0a1Z2SGdXS2xXOTJMcXVlV1RjWExYWi1j?oc=5","date":"2026-03-11","type":"pipeline","source":"GlobeNewswire","summary":"CERo Therapeutics Provides Shareholder Update - GlobeNewswire","headline":"CERo Therapeutics Provides Shareholder Update","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxNeEVUNnhKZDlpaW5meWtLQ3dxenF2VjVZVnlMbjlNeDdzT25KYnN0OE5VMU9ELVg4LVB4UC1VNlNXR2hBcG5EanBSNjFLcm5GaW1FdHBtN1h6YWhpQ0RvMXVKOWo5dWFMSmNSYVhYN0FnS3EzQ1B5eDhNc0RfQlV5LXp5dGlBSlRUd1hoV0tDbmdJMVBVakQzajJscjdTMDdXQXB1RUxKUlY1YURQUXhmdGM5XzRjT0J3cGxJ?oc=5","date":"2026-03-10","type":"pipeline","source":"Stock Titan","summary":"CERO Therapeutics (CERO) secures up to $1M through 10% convertible note - Stock Titan","headline":"CERO Therapeutics (CERO) secures up to $1M through 10% convertible note","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_gFBVV95cUxQemhjMWgxc292ZXJNOWprS0FNUk9raGoxdlVVakRvSmpzWFVZRnRialVPUTRNNnVLZzdkY3FweGF6eDVqLXplLUoybGZzRm96aGhFZUxsY3NGckhUTmQyOUxuUFlhZEJoVUh4d1lMeTlEd0RYbkwwQUl2WDFVUGplakpwb1FNLWVET0lkQnAxaEVnT0lFLTQwZlZDcTB4VVlZcnJyRVFEQmFUVmNscnpIVkNscmN1ZFNUS2JSZWUwd1ZVX0hWMWZ5cDRWdDFka0Juc2pOaUprVEJpaGU4akE1TVhtTEptRldfektOMVhtNHg0OXFPWXA1b0IxNVF1dw?oc=5","date":"2026-02-17","type":"pipeline","source":"GlobeNewswire","summary":"CERo Therapeutics Announces Biotech Industry Veteran Eric Francois to Join its Board of Directors - GlobeNewswire","headline":"CERo Therapeutics Announces Biotech Industry Veteran Eric Francois to Join its Board of Directors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxPSF94a1hNMjI5dkZQZ3JZX0E3elkxd2pLUkZrZ1cwbXhDLWtoSHZWOEQyN2NPdnEwRnprSWVYb0VsWmVIWTkta1VGTV9ldEpDY2hzcGw0bXdPVzBqUVFLaDRDR3FrMEtnTUExQkdlbHpDbjB6NnR6eG9qWXZMeFFWOGJhYTJ0NXVhU2FZWnVhd3pnekdtQWNjb185SldzU3QzTUNjbUdESjNDcW1EMl9XNERXVW12SzRtRTN4ZXR1dy1WSVN6aVh1MGlKVVFiMGh3MjFr?oc=5","date":"2025-10-29","type":"pipeline","source":"GlobeNewswire","summary":"CERo Therapeutics Announces Receipt of Nasdaq Panel Determination - GlobeNewswire","headline":"CERo Therapeutics Announces Receipt of Nasdaq Panel Determination","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxNUHFGZDdTRVBwZXgyZ0QzRXpXdlUyUG9vVldEQWVCeGY5ZHRDV2JidHA4LURERWtuRDZZbVhJTGJhWHlMUjBNN2RvUjFHRnpIMjd2Z0xfcjd2b0dILTBCNWhHRVhvMXBmdUpBMW5HT1J3TzZwd3RiNmNqWVVMOU0xUVE0WVBsRzg2YjZXdkNackRvdVQwNjFSSw?oc=5","date":"2025-10-10","type":"pipeline","source":"Axios","summary":"CERo Therapeutics CEO: We're \"open\" to takeover offers - Axios","headline":"CERo Therapeutics CEO: We're \"open\" to takeover offers","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxPTFYzVjdTejhSdDgzekZyaGdfUlFRWTBnYUh4RXFZVzlCci15NWNKMmp2Rk5IZ0FxYU9FWllkczhQRnpKei1USk5reDhTMEZGMDJVM2ZscnpIU1Rkc2JXOVQ5UFNza3dLUHFEZE5FZEliZE8xZ3dEbzRPWWVSLWEwV2hRUXVSMzBfa1loMkdRLWhvZk1MTlNLWkRCZUE1d0Vuek41cDU0bw?oc=5","date":"2025-10-07","type":"regulatory","source":"Oncology News Central","summary":"Oncology Drugs Granted FDA Designations in September 2025 - Oncology News Central","headline":"Oncology Drugs Granted FDA Designations in September 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTE55TmFRbHRoZUJCLWhhZWFUcXpuUURHclp3eGVLMlRLeW9KZTJ6TDUwblZNRTlQdk9yTEVDNXlGd3FsZnZsbTRYSTZ3NElCZ2dZZHlGODVrTUNXaURS?oc=5","date":"2025-08-23","type":"pipeline","source":"Finimize","summary":"CERo Therapeutics Sits On A High-Risk, High-Reward Biotech Bet - Finimize","headline":"CERo Therapeutics Sits On A High-Risk, High-Reward Biotech Bet","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMia0FVX3lxTE9SY1V4OEdHSnNWM0JXSXUxemFia0xTSmlfeE5ZRTg0MXJsOFZsRUs3MkZTU29hWnNEWWg1RGlJdmFKcmNZQ282UDVsODNsR1FNNU5qaUpwUG9UTjR2ZVdiVm53Zl83NzYzVElN?oc=5","date":"2025-07-16","type":"pipeline","source":"MarketBeat","summary":"Jason Kolbert Analyst Performance at D. Boral Capital - MarketBeat","headline":"Jason Kolbert Analyst Performance at D. Boral Capital","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1wJBVV95cUxNVm03NjFRYmczTm9yMnRIVDVaRVdSdGNOeXhLMTBpcnpXNjZDTVVIbE5ITVdQMFpCUjFWQTY1OE1UV1QxYXFibmVlSkdwSFBuWjZWaGZIbzh1NVJTUTFVWG9QNnV4TXZUdm9VaGJzRU5SRXhKSzZHSTdwMmtYemhad2Qyc054M1djckQ3ZjRrUHdnS2hPUVlaMkFTZXNpSzQ4cTNOSEM2aHotUHNJQlgzdkNGWG9NaFhuMzVZZlJ6WG9xQWV2a0FYVzZfYjRnOGtzaTJ0dlQxeE0xc1lzc3JZYS1GbDVMR0szSGgweTVxdS04UlV3Q0l6ZUU5Yk9vcmE0X1BVdnAzd0JzU0FkYmtNRk13a2xnM0lGQTBDZVltQkptLVpyRHljWE1yUEJzekdLTHVQMFd2V1UxSU0tdGM2TUVDYWlaMGhiN1VlN1pxd2RTejZqdnJr?oc=5","date":"2025-07-07","type":"regulatory","source":"businesswire.com","summary":"Invivoscribe Expands Flow Cytometry Services to Accelerate CAR-T Immunotherapy Development and Regulatory Readiness with the Initiation of CERo Therapeutics Phase 1 Clinical Trial - businesswire.com","headline":"Invivoscribe Expands Flow Cytometry Services to Accelerate CAR-T Immunotherapy Development and Regulatory Readiness with","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUkFVX3lxTE84dTE5NDNzTEQ1Y0dDRXM4UG9rZkNYdTJ5MUYwN1NYNWhObkxFRGNpMkQ5UkctazZCcm41bHVrQkhfZ0Ywb3RiYXZLS0dmTXJFa3c?oc=5","date":"2024-03-24","type":"pipeline","source":"Yahoo Finance Singapore","summary":"CERo Therapeutics Holdings, Inc. (CERO) stock price, news, quote and history - Yahoo Finance Singapore","headline":"CERo Therapeutics Holdings, Inc. (CERO) stock price, news, quote and history","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}